NONMEM Users Network Archive

Hosted by Cognigen

GVKBIO and Quantitative Solutions to Launch Clinical Outcome Databases

From: Sreeni Devidas <sreeni.devidas>
Date: Thu, 1 Oct 2009 18:26:43 +0530

GVK BIO, Asia's leading integrated research services provider and
Quantitative Solutions (QS), a leading modeling and simulation
consultancy to the pharmaceutical and biotech industry, have formed a
strategic alliance partnership to develop and market clinical trial
outcomes databases in high value disease areas.

* The databases capture summary level data for the clinical
safety and efficacy outcomes from publicly available data sources.
Models derived from them can be used to characterize the probability
distribution of clinical efficacy and tolerability as a function of
various treatment and patient factors.

* The databases can help companies conduct comparative efficacy
and safety analysis, link/scale biomarkers to clinical outcomes,
predict/improve trial outcome, and develop product differentiation
strategies.

* The databases are supported by customization and M&S
consulting services provided by GVK Bio and QS, respectively, to ensure
maximum flexibility and benefits to our clients

 

GVK BIO will distribute globally existing QS Databases in five
indications including Rheumatoid Arthritis & Psoriasis, Chronic HCV,
Neuropathic Pain, Osteoporosis (postmenopausal) and Major Depression
immediately. GVK BIO and QS plan to jointly develop and market
additional databases in Dyslipidemia, Schizophrenia, Alzheimer's, and
other indications shortly.

 

.

Best regards,

 

Sreeni

Sreeni Devidas Ph.D.
Vice President Business Development
GVK BioSciences
5457 Twin Knolls Road
Suite 101
Columbia, MD 21045
Tel: 443-838-6260
Fax: (703) 940 4088
www.gvkbio.com <http://www.gvkbio.com/>

 

 


 





Notice: The information contained in this electronic mail message is inte=
nded only for the use of the designated recipient. This message is privileg=
ed and confidential. and the property of GVK BIO or its affiliates and subs=
idiaries. If the reader of this message is not the intended recipient or an=
 agent responsible for delivering it to the intended recipient, you are her=
eby notified that you have received this message in error and that any revi=
ew, dissemination, distribution, or copying of this message is strictly pro=
hibited. If you have received this communication in error, please notify us=
 immediately by telephone +91-40-66929999 and destroy any and all copies of=
 this message in your possession (whether hard copies or electronically sto=
red copies).
Received on Thu Oct 01 2009 - 08:56:43 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request@iconplc.com.

Once subscribed, you may contribute to the discussion by emailing: nmusers@globomaxnm.com.